Pion Inc.

The decision makers in Pion Inc. are Balint Sinko, Dan Klevisha, Haotian Wang, etc. Click to Find Pion Inc. decision makers emails.

Pion Inc. provides a range of in vitro scientific instruments designed to support various aspects of drug development. These include instruments for formulation development, particle analysis, permeability testing, and biorelevant dissolution studies. Each instrument is engineered to deliver accurate and timely data, facilitating informed decision-making throughout the drug development process.

Pion's contract research services offer expertise in various areas of drug development, including solubility, lipophilicity (log P/log D), and ionization constant (pKa) determination. By leveraging Pion's specialized knowledge and advanced technologies, clients can accelerate their research timelines, reduce costs, and enhance the reliability of their data, ultimately leading to more successful drug development outcomes.

Biopharmaceutics Classification System (BCS) screening is crucial in drug development as it helps predict the solubility and permeability of drug compounds. Pion Inc. offers BCS screening services that assist researchers in classifying their compounds, which can inform formulation strategies and regulatory submissions. This process is essential for optimizing drug delivery and ensuring efficacy in clinical applications.

Yes, Pion Inc. provides comprehensive equipment maintenance services for their scientific instruments. Regular maintenance ensures that the instruments operate at peak performance, reducing downtime and maintaining the accuracy of experimental results. Pion's skilled technicians are trained to service a variety of instruments, ensuring that clients can rely on their equipment for consistent and reliable data.

Pion Inc. primarily supports the pharmaceutical and biotechnology industries, providing solutions tailored to the needs of drug developers. Their expertise in formulation development, permeability testing, and dissolution studies makes them a valuable partner for companies engaged in drug discovery and development. Additionally, Pion's services can benefit academic research institutions and contract research organizations (CROs) involved in similar scientific endeavors.

The Parallel Artificial Membrane Permeability Assay (PAMPA) is a widely used method for assessing the permeability of drug compounds across biological membranes. Pion Inc. offers PAMPA testing services that help researchers evaluate the absorption potential of their drug candidates. By providing accurate permeability data, Pion assists clients in optimizing their formulations and making informed decisions regarding the viability of their compounds in clinical settings.